Defender Capital, LLC. - Q1 2021 holdings

$280 Million is the total value of Defender Capital, LLC.'s 38 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was - .

 Value Shares↓ Weighting
OCX NewONCOCYTE CORP$3,122,000604,450
+100.0%
1.11%
RUN NewSUNRUN$2,453,0005,000
+100.0%
0.88%
PTN NewPALANTIR TECHNOLOGIES$2,316,00010,000
+100.0%
0.83%
VSAT NewVIASAT INC$288,0006,000
+100.0%
0.10%
ITMR NewITAMAR MEDICAL$287,00012,000
+100.0%
0.10%
ARWR NewARROWHEAD PHARMACUTICLES$270,0004,000
+100.0%
0.10%
KMI NewKINDER MORGAN INC$250,00015,000
+100.0%
0.09%
CSCO NewCISCO SYSTEMS INC$208,0004,016
+100.0%
0.07%
ATNX NewATHENEX INC$86,00020,000
+100.0%
0.03%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-04-20
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BERKSHIRE HATHAWAY INC DEL CL B20Q3 202324.4%
DANAHER CORPORATION COM20Q3 202318.3%
STAAR SURGICAL CORPORATION20Q3 202320.2%
FORTIVE CORPORATION20Q3 202314.3%
MONSTER BEVERAGE CORPORATION20Q3 202317.3%
APPLE INC20Q3 20230.6%
AMAZON INC COM20Q3 20230.4%
VANGUARD SHORT TERM TREASURY ETF IV17Q3 202323.9%
LINEAGE CELL THERAPEUTICS INC17Q3 20234.8%
COMPUGEN LTD ORD17Q1 20231.9%

View Defender Capital, LLC.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-06
13F-HR2024-01-23
13F-HR2023-10-23
13F-HR2023-07-18
13F-HR/A2023-05-16
13F-HR2023-04-27
13F-HR2023-01-12
13F-HR2022-10-18
13F-HR2022-07-26
13F-HR/A2022-06-07

View Defender Capital, LLC.'s complete filings history.

Compare quarters

Export Defender Capital, LLC.'s holdings